Singapore, 13 May 2022 – Actxa Pte.Ltd (“Actxa”), a homegrown AI-driven preventive health solutions company, has been awarded the SBR Technology Excellence Award in the AI – Healthcare Technology category for its Non-Invasive Blood Glucose Monitoring (“BGM”) project. Actxa is the first Singapore company to develop a comprehensive AI solution that leverages consumer-grade wearables to detect blood glucose dysregulation. The BGM is also the only non-invasive blood glucose detection solution to be going through a clinical validation study in Southeast Asia. The latest Singapore National Population Health Survey shows that 9.5% of adults have diabetes from 2019 to 2020. Nearly a quarter of them are newly diagnosed, whilst 26% exhibit poor glucose control¹. In 2017, the Singapore Ministry of Health launched a nationwide initiative to tackle the epidemic of diabetes, and advances in wearable technologies may be the key to alleviating this problem. As a company with a vision to be a leading preventive health technology company in the world, Actxa’s research and development (“R&D”) team began working on a novel digital monitoring technology in 2016, which was later coined as BGM. Its goal was to engineer a solution that is non-invasive, frequently and conveniently accessible, and low cost. The innovative non-invasive BGM solution detects glucose dysregulation in patients with diabetes or prediabetes. It leverages the latest technological advancement in signal processing, wearable technologies, and artificial intelligence (“AI”) to assess the risk of impaired glucose regulation. Using inter-beat-interval data from a consumer-grade wrist-worn photoplethysmography (“PPG”) sensor, the AI model will compute the relevant digital biomarkers correlated with the symptoms of prediabetes or Type 2 diabetes mellitus (T2DM), and eventually predict the risk of developing diabetes. Joel Chin, Actxa’s Chief Executive Officer, said, “It is a great honour of Actxa to be a recipient of the SBR Technology Excellence Awards 2022. We want to thank the Singapore Business Review and the judges for recognising Actxa’s accomplishments. This is the best form of recognition for the R&D team who has been working on this project for the past five years. It is a testament of our commitment to being at the forefront of innovation, and we will continue doing so for the betterment of public health.” This technology is undergoing conducting a clinical validation study with a local hospital to improve the prediction model and evaluate the model’s real-world accuracy, reliability, and generalisability. The BGM will be available as a B2B cloud service with the production of at least one wearable product by quarter four of 2022. About Actxa Actxa was founded in 2015 with the mission to bring together people, partners, science, technology, and data to create positive changes to the health, quality of life and well-being of individuals and communities. Leveraging on our expertise in developing evidence-based and personalised insights through Artificial Intelligence, we empower individuals to make informed decision on their health and well-being and to make timely changes to their lifestyle. Actxa sets its focus on research and development on innovative preventive health solutions and we work closely with industry and academic partners to explore new opportunities. About SBR Technology Excellence Awards Organised by the Singapore Business Review, the SBR Technology Excellence Awards is the most prestigious awards programme for technological innovations, recognising exceptional companies in Singapore that are riding the digital disruption wave and leading the technological revolution and digital journeys of their respective industries. The SBR Technology Excellence Awards is part of the regional Asian Technology Excellence Awards now running in 50 countries. References: [1] National Population Health Survey 2020, MOH. https://www.moh.gov.sg/docs/librariesprovider5/default-document-library/nphs-2020-survey-report.pdf. For further information, please contact: Tan Lay Eng Corporate Communications Manager layeng.tan@actxa.sg +65 9877 0406

For immediate release Singapore, 15 July 2022 – This year, Actxa Pte. Ltd (“Actxa”) has partnered with the Singapore Heart Foundation (SHF) as a product sponsor with our Actxa Spark+ fitness trackers and Actxa Sense 2 Smart Scale for their year-long heart health awareness campaigns. Going beyond sponsorship, Actxa along with its sister companies, Activate Interactive Pte Ltd (“Activate”) and Actxa Wellness will be partaking in multiple SHF programmes. Between 4 to 26 June 2022, 21 of our staff from Actxa, Activate and Actxa Wellness, participated in SHF’s Pledge Your Heart Walk (PYHW), clocking over 120 kilometres. PYHW was held in conjunction with the Go Red for Women campaign to encourage women to stay active to reduce their risk of cardiovascular disease and improve their mental health. Earlier in May 2022, Actxa had also supported the SHF’s Mummy’s Heartbeat community education event and May Blood Pressure Measurement Month intended to promote heart health awareness in Singapore. Actxa, Activate and Actxa Wellness will also be participating in the Restart A Heart Programme (RAH) that will be held in our office premises on 1 August 2022. RAH is a simplified CPR+AED training, designed for those who want to learn some basic resuscitation skills but do not require certification. Actxa is also sponsoring the lucky draw prizes for the SHF Charity Cup Golf Tournament 2022 that will be held on 27 July 2022 to raise funds for needy heart patients and contribute to SHF’s various free or subsidised programmes, such as heart health awareness events, CPR+AED courses and cardiac rehabilitation for heart patients. Joel Chin, CEO of Actxa , said, “Actxa is pleased to support the Singapore Heart Foundation by sponsoring our Actxa products in support of their heart health awareness campaigns. As an AI-driven preventive health solutions company, we create insights and bespoke programmes to help people reduce the risks of chronic diseases, such as cardiovascular disease. The works of SHF resonate with our belief in building a healthier future for individuals from all walks of life. We will continue to support and advocate for preventive health care awareness and remain committed to inspire and empower people to make proactive moves to live better and healthier.” About Actxa Actxa was founded in 2015 with the mission to bring together people, partners, science, technology, and data to create positive changes to the health, quality of life and well-being of individuals and communities. Leveraging on our expertise in developing evidence-based and personalised insights through Artificial Intelligence, we empower individuals to make informed decision on their health and well-being and to make timely changes to their lifestyle. Actxa sets its focus on research and development on innovative preventive health solutions and we work closely with industry and academic partners to explore new opportunities. For more information, please visit https://actxa.com About Singapore Heart Foundation Singapore Heart Foundation is a social service agency at the forefront of the battle against heart diseases in Singapore. Since its inception in 1970, the Foundation has grown into a well-established and reputable organisation with local and international links. Through strategic lifesaving programmes under the three core pillars of Prevention, Rehabilitation and Resuscitation, SHF fulfills its mission to promote heart health, prevent and reduce disability and death due to cardiovascular disease and stroke. In addition, SHF also offers financial assistance to needy heart patients for emergency relief and medical treatment. For further information, please contact: Tan Lay Eng Corporate Communications Manager layeng.tan@actxa.com +65 9877 0406 Hasyimah Begum AJ Corporate Communications Executive hasyimah.aj@actxa.com +65 8780 3620

The MOU was signed by Mr Joel Chin, CEO of Actxa (left), and Mr James Yan, CEO of Joint Chinese Limited (right). Photo by: Actxa Pte Ltd Singapore, 3 August 2022 – Actxa Pte. Ltd (“Actxa”) and Joint Chinese Limited (“JC”) alongside its associated group of companies, signed a Memorandum of Understanding (“MOU”) on 2 August 2022, to join hands in market penetration and expansion for Pre-M Diabetes ™ , also known as the Non-Invasive Blood Glucose Monitoring technology. We will be targeting the consumer wearables, senior care and home care segment in China. Both will also work closely on the worldwide distribution of JC’s wearables powered by Pre-M Diabetes ™ . Actxa and JC will collaborate to incorporate Pre-M Diabetes ™ and other physiological health insights (“Actxa Insights”) in JC’s products and services, develop business and establish marketing and brand presence in China. Both sides will also be involved in research collaborations in China to further develop Actxa Insights. JC is a leading manufacturer and solution provider for digital health wearables in China. JC has identified at least 11 models of their wearables that have the potential to include Pre-M Diabetes ™ to ship within China and worldwide. Actxa is the first Singapore company to develop a comprehensive AI solution that leverages consumer-grade wearables to detect blood glucose dysregulation. The Pre-M Diabetes ™ is also the only non-invasive blood glucose detection solution to be going through a clinical validation study in Southeast Asia. In Singapore, at least 1 million people are projected to have diabetes by 2050 and 1 out of 4 will be undiagnosed¹. Worldwide, about 643 million people will be diabetic by 2030, and 1 in 2 adults will be undiagnosed². Through regular blood glucose monitoring, the increased risk for developing diabetes can be detected early. The launch of the Pre-M Diabetes ™ allows individuals to monitor their blood glucose levels in a pain-free, easy and frequent way. The regular measurement of blood glucose will help individuals prevent, delay the onset or in some situations, even reverse the condition. Joel Chin, Actxa’s Chief Executive Officer , said, “This MOU builds on our existing strong partnership with JC, and we are honoured to collaborate with JC in launching and distributing the Pre-M Diabetes ™ in China and the rest of the world. This strategic alliance leverages the strengths of both companies to create a significant impact in the global fight against diabetes. We are confident that Pre-M Diabetes ™ will help individuals make informed health decisions and positive lifestyle changes to reduce the risk of developing Type 2 diabetes.” Mr. James Yan, Chief Executive Officer of Joint Chinese Limited , said, “Actxa and Joint Chinese Limited are forerunners in wearable technology, and the cooperation between the two parties has entered the eighth year. Focusing on cutting-edge technologies related to human health, both teams have constantly worked together to improve the synergy and uncover tacit knowledge to drive more innovation. The accuracy of data collection has also improved. The series of Pre-M Diabetes ™ products is the result of our joint efforts, boosting new opportunities in the global preventive health market. Joint Chinese Limited will continue to sustain and pursue quality work, while achieving success with Actxa.” The Pre-M Diabetes ™ has also won Actxa an award under the AI – Healthcare Technology category in the annual SBR Technology Excellence Awards, hosted by Singapore Business Review. The SBR Technology Excellence Awards is part of the regional Asian Technology Excellence Awards now running in 50 countries³. References: https://www.healthhub.sg/live-healthy/1273/d-day-for-diabetes https://idf.org/aboutdiabetes/what-is-diabetes/factsfigures.html#:~:text=The%20total%20number%20of%20people,living%20with%20dia betes%20are%20undiagnosed https://sbr.com.sg/event-news/actxa-wins-ai-award-its-non-invasive-blood-glucosemonitoring-project For further information, please contact: Tan Lay Eng Communications Manager layeng.tan@actxa.com +65 9877 0406 Hasyimah Begum AJ Communications Executive hasyimah.aj@actxa.com +65 8780 3620 About Actxa Actxa was founded in 2015 with the mission to bring together people, partners, science, technology, and data to create positive changes to the health, quality of life and well-being of individuals and communities. Leveraging our expertise in developing evidence-based and personalised insights through Artificial Intelligence, we empower individuals to make informed decision on their health and well-being and to make timely changes to their lifestyle. Actxa sets its focus on research and development on innovative preventive health solutions, and we work closely with industry and academic partners to explore new opportunities. For more information, visit www.actxa.com . About Joint Chinese Group Founded in 2004, Joint Chinese Ltd. is a High-tech manufacturer with Medical Qualification, specialized in Smart Health & Medical Care Product in China. We have 3 production bases with total of 20,000sqm and strong R&D team of more than 120 engineers. We operate in 100+ countries and regions, collaborating with most recognized brands, including Xiaomi, Walmart, LG. Specialized in OEM/ODM one-stop service, we have plant area of 12,000 sq meter with monthly production capacity of 1000,000 pcs. For more information, visit https://www.jointcorp.com/ .

(Media Source: Hardware Zone) Local health-tech brand, Actxa , has just launched their latest activity tracker, the Spark+ Series 2 ( Spark+ S2 ). This newest model comes with a range of features, including an advanced sleep tracking technology called SleepTrack , all-day heart rate and heart rate variability monitoring , outdoor workouts with real-time maps (assisted GPS), and VO2 Max support. It also has a 3-axis accelerometer . According to Actxa, SleepTrack provides in-depth analysis of sleep quality, generating detailed sleep reports. For outdoor workouts, the activity tracker can now provide real-time displays of your workout route, but as it does not have built-in GPS, you can’t leave your phone behind. The Spark+ S2 is a lightweight (24g ) device mostly made of plastic with a TPU strap. It features a 0.96-inch TFT touch display, with IP67 water-resistance, and 110mAh battery. Actxa says the tracker should last up to 7-days of standard usage, but only 30 hours with continuous heart-rate monitoring. Connectivity is based on Bluetooth 4.0 BLE . The Spark+ S2 activity tracker is available now on Actxa's Official Lazada Store for S$70 .

(Media Source: NXT) Actxa, a locally-grown AI-driven deep tech company, proudly introduces its latest addition to the health and fitness monitoring product line, the Spark+ Series 2 (“Spark+ S2”). This cutting-edge activity tracker is designed to provide all-around health and fitness monitoring, featuring a host of new and improved features compared to its predecessor, the Spark+. Enhanced with Advanced SleepTrack™ Technology One of the standout features of the Spark+ S2 is Actxa’s SleepTrack™ technology, taking sleep tracking to new heights. It goes beyond basic sleep monitoring, analyzing various metrics to offer comprehensive insights into an individual’s sleep quality. Recognizing the significance of sleep for physical and mental well-being, the Spark+ S2 helps track sleep quality, generating detailed sleep reports for each sleep cycle, along with a sleep score to monitor progress over time and ensure restful nights. All-Day Heart Rate (HR) and Heart Rate Variability (HRV) Monitoring With all-day heart rate (HR) and heart rate variability (HRV) monitoring, the Spark+ S2 provides valuable insights into how users’ hearts respond to various activities and events throughout the day. Whether awake, asleep, or during workouts, users can gain a deeper understanding of their heart’s performance and make informed lifestyle adjustments accordingly. Real-Time Outdoor Workouts with GPS The Spark+ S2 accompanies users during outdoor workouts, displaying real-time workout routes through their phone’s GPS feature. This functionality allows them to monitor the distance covered and track their progress with comprehensive performance reports, enhancing their fitness journey. Measure Your VO2 Max for Optimal Fitness With Actxa’s advanced VO2 Max algorithm, users can measure their fitness level and fitness age through brisk walks or runs. By tracking their VO2 Max over time, they can gauge the effectiveness of their exercise routines and make informed decisions to optimize their fitness goals. Unparalleled Insights via the Actxa App The Spark+ S2 provides users with invaluable insights and data to optimize their well-being through the Actxa App. The app conveniently generates reports of workout statistics, heart rate zones, and heart rate performance during workouts, enabling users to track their progress and make necessary adjustments. Fashionable and Holistic Progress Tracking Sporting a sleek, slim, and fashionable design, the Spark+ S2 is not only a powerful health and fitness companion but also a stylish accessory. With this activity tracker, users can holistically harness their health and fitness potential, taking steps to prevent or delay the onset of chronic diseases. Available Now on Actxa’s Lazada Platform The Spark+ S2 is now available for purchase on Actxa’s Lazada platform for SGD$70. To make the most of this advanced activity tracker, users can download the Actxa app from the Google Play Store or Apple Store.